A detailed history of Jones Financial Companies Lllp transactions in Novo Nordisk A S stock. As of the latest transaction made, Jones Financial Companies Lllp holds 44,582 shares of NVO stock, worth $4.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
44,582
Previous 22,011 102.54%
Holding current value
$4.69 Million
Previous $3.14 Million 68.99%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $2.69 Million - $3.28 Million
22,571 Added 102.54%
44,582 $5.31 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $2.05 Million - $2.46 Million
16,744 Added 317.9%
22,011 $3.14 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $494,518 - $658,260
4,843 Added 1142.22%
5,267 $676,000
Q4 2023

Feb 13, 2024

SELL
$87.78 - $105.45 $4,915 - $5,905
-56 Reduced 11.67%
424 $43,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $37,740 - $82,809
415 Added 638.46%
480 $43,000
Q2 2023

Aug 09, 2023

SELL
$155.98 - $172.65 $6,551 - $7,251
-42 Reduced 39.25%
65 $10,000
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $7,543 - $9,070
-57 Reduced 34.76%
107 $17,000
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $1,435 - $1,894
14 Added 9.33%
164 $22,000
Q3 2022

Nov 03, 2022

SELL
$95.28 - $116.93 $3,334 - $4,092
-35 Reduced 18.92%
150 $15,000
Q2 2022

Aug 08, 2022

SELL
$103.24 - $121.81 $412 - $487
-4 Reduced 2.12%
185 $21,000
Q1 2022

May 02, 2022

SELL
$93.1 - $112.54 $41,895 - $50,643
-450 Reduced 70.42%
189 $21,000
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $13,806 - $16,859
144 Added 29.09%
639 $72,000
Q1 2021

Apr 30, 2021

BUY
$67.06 - $75.82 $8,986 - $10,159
134 Added 37.12%
495 $33,000
Q4 2020

Feb 08, 2021

BUY
$63.89 - $73.8 $23,064 - $26,641
361 New
361 $25,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.